Opus Genetics (IRD)

Opus Genetics (IRD) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• IRD last traded at $3.67, 0.55% on the day.
• Opus Genetics: P/E -2.9, revenue $9.86M over the last four quarters.
• Over the past year IRD returned 86.29%; year to date 82.59%.

Updated 2026-11-02 18:23 UTC